NIFTY 50 INDEX
25,935.15
25,935.15
+0.26% ▲ Bulls Leading 🚀
Valuation Analysis
The estimated Price-to-Earnings (P/E) Ratio for India Stock Market is 23.87, calculated on 09 February 2026. Considering the last 5 years, an average P/E interval is [21.84 , 24.32].
For this reason, the current P/E can be considered Fair
P/E Ratio is calculated on the INDA Etf, whose benchmark is the India Stock Market.
Current P/E
22.85
22.85
1Y Median Forecast
7.32%
7.32%
📌 Statistical Note: The “1Y Median Forecast” is an automated projection derived from a 25-year statistical distribution of historical median returns for this valuation tier. It represents the central tendency of past data and is for analytical purposes only.
⚠️ Disclaimer: This update is automated for informational purposes only. It does NOT constitute a buy or sell call, financial advice, or an investment recommendation. Market returns are subject to volatility and past performance is not indicative of future results. Consult a SEBI-registered advisor before making investment decisions.
🚀 Leading Sectors
Media
+2.40%
+2.40%
Key Constituents: Zee Ent, Sun TV, PVR Inox, Network18, TV18 Broadcast, Nazara Tech, Dish TV, Hathway, Saregama, Tips Industries
Automobile
+1.37%
+1.37%
Key Constituents: M&M, Maruti, Tata Motors, Bajaj Auto, Eicher Motors, TVS Motor, Hero MotoCorp, Ashok Leyland, MRF, Balkrishna Ind
Metals
+0.81%
+0.81%
Key Constituents: Tata Steel, JSW Steel, Hindalco, Jindal Steel, Vedanta, NMDC, SAIL, National Aluminium, APL Apollo, Ratnamani
PSE
+0.55%
+0.55%
Key Constituents: NTPC, ONGC, Power Grid, Coal India, BEL, HAL, BPCL, IOC, PFC, REC
🔻 Laggard Sectors
Nifty Bank
-0.07%
-0.07%
Under Pressure: HDFC Bank, ICICI Bank, SBI, Axis Bank, Kotak Bank, IndusInd Bank, Bank of Baroda, PNB, IDFC First, Federal Bank
PSU Bank
-0.19%
-0.19%
Under Pressure: SBI, Bank of Baroda, Canara Bank, Union Bank, IOB, PNB, Indian Bank, Bank of India, UCO Bank, Central Bank
Pharma
-0.36%
-0.36%
Under Pressure: Sun Pharma, Cipla, Dr Reddys, Lupin, Aurobindo Pharma, Zydus Life, Divis Lab, Alkem, Torrent Pharma, Abbott